The long-awaited revision of the industry standard on phylogenetics

Since the publication of the first edition of this landmark volume more than twenty-five years ago, phylogenetic systematics has taken its place as the dominant paradigm of systematic biology. It has profoundly influenced the way scientists study evolution, and has seen many theoretical and technical advances as the field has continued to grow. It goes almost without saying that the next twenty-five years of phylogenetic research will prove as fascinating as the first, with many exciting developments yet to come.

This new edition of "Phylogenetics" captures the very essence of this rapidly evolving discipline. Written for the practicing systematist and phylogeneticist, it addresses both the philosophical and technical issues of the field, as well as surveys general practices in taxonomy. Major sections of the book deal with the nature of species and higher taxa, homology and characters, trees and tree graphs, and biogeography--the purpose being to develop biologically relevant species, character, tree, and biogeographic concepts that can be applied fruitfully to phylogenetics.

The book then turns its focus to phylogenetic trees, including an in-depth guide to tree-building algorithms. Additional coverage includes:

Parsimony and parsimony analysis

Parametric phylogenetics including maximum likelihood and Bayesian approaches

Phylogenetic classification

Critiques of evolutionary taxonomy, phenetics, and transformed cladistics

Specimen selection, field collecting, and curating

Systematic publication and the rules of nomenclature

Providing a thorough synthesis of the field, this important update to "Phylogenetics" is essential for students and researchers in the areas of evolutionary biology, molecular evolution, genetics and evolutionary genetics, paleontology, physical anthropology, and zoology.

Sets the foundation for safer, more effective drug therapies

With this book as their guide, readers will discover how to apply our current understanding of the pharmacogenomics of drug transporters to advance their own drug discovery and development efforts. In particular, the book explains how new findings in the field now enable researchers to more accurately predict drug interactions and adverse drug reactions. Moreover, it sets the foundation for the development of drug therapies that are tailored to an individual patient's genetics.

"Pharmacogenomics of Human Drug Transporters" serves as a comprehensive guide to how transporters regulate the absorption, distribution, and elimination of drugs in the body as well as how an individual's genome affects those processes. The book's eighteen chapters have been authored by a team of leading pioneers in the field. Based on their own laboratory and clinical experience as well as a thorough review of the literature, these authors explore all facets of drug transporter pharmacogenomics, including: Individual drug transporters and transporter families and their clinical significancePrinciples of altered drug transport in drug-drug interactions, pharmacotherapy, and personalized medicineEmerging new technologies for rapid detection of genetic polymorphismsClinical aspects of genetic polymorphisms in major drug transporter genesFuture research directions of drug transporter pharmacogenomics and the prospect of individualized medicine

"Pharmacogenomics of Human Drug Transporters" opens the door to new drug discovery and development breakthroughs leading to safer and more effective customized drug therapies.The book is recommended for pharmaceutical scientists, biochemists, pharmacologists, clinicians, and genetics and genomics researchers.

This resource provides thorough coverage of pharmacogenetics and its impact on pharmaceuticals, therapeutics, and clinical practice. It opens with the basics of pharmacogenetics, including drug disposition and pharmacodynamics. The following section moves into specific disease areas, including cardiovascular, psychiatry, cancer, asthma/COPD, adverse drug reactions, transplantation, inflammatory bowel disease, and pain medication. Clinical practice and ethical issues make up the third section, with the fourth devoted to technologies like genotyping, genomics, and proteomics. In the fifth part, chapters discuss the impact of key regulatory issues on the pharmaceutical industry.

The early promise of genetic engineering triggered a host of social and political concerns. In Molecular Politics, Susan Wright draws on government records, archival materials, and a wide range of interviews to analyze how the American and British governments responded to these concerns and to the struggles among corporations, scientists, universities, trade unions, and public interest groups for control of this controversial technology. Advancing an original approach to the expression of power in policymaking, she provides the first comparative study of a crucial set of policy decisions and explores their implications for the political economy of contemporary science.

Mutant Ecologies traces the spinning of new synthetic threads into the web of life. It is a critical cartography of the shifting landscapes of capital accumulation conjured by recent developments in genomic science, genome editing and the biotech industry. CRISPR crops, fast-growing salmons, heat-resistant Slick (TM) cows, Friendly (TM) Mosquitoes, humanised mice, pigs growing human organs - these are but a few of the dazzling new life-forms that have recently emerged from corporate and university laboratories around the world, all promising to lubricate the circuits of capital accumulation in distinct ways. The deliberate induction of genetic mutations is increasingly central to business operations in a number of sectors, from agriculture to pharmaceuticals. While the Nobel Committee recently proclaimed the life sciences to have entered 'a new epoch', the authors show how these technological innovations continue to operate within a socio-historical context defined by the iron rules of capitalist competition and exploitation. Capital no longer contents itself with simply appropriating the living bodies of plants and animals. It purposefully designs their internal metabolism, and in that way it redesigns the countless living vectors that constitute the global biosphere. It is driving a biological revolution, which will ripple through the everyday lives of people everywhere.

Long before scientists at the Roslin Institute in Scotland cloned Dolly the sheep in 1996, American developmental biologist and aspiring cancer researcher Robert Briggs successfully performed the technique of nuclear transplantation by cloning frog nuclei in 1952. Although the history of cloning is often associated with contemporary ethical controversies, The Forgotten Clones revisits the influential work of scientists like Briggs, Thomas King, and Marie DiBerardino, before the possibility of human cloning and its ethical implications first registered as a concern in public consciousness, and when many thought the very idea of cloning was experimentally impossible. By focusing instead on new laboratory techniques and practices and their place in Anglo-American science and society in the mid-twentieth century, Nathan Crowe demonstrates how embryos constructed in the lab were only later reconstructed as ethical problems. His book illuminates the importance of the early history of cloning for the biosciences and their institutional, disciplinary, and intellectual contexts, as well as the changing relationship between science and society after the Second World War.

This new volume, Biocatalysis and Agricultural Biotechnology: Fundamentals, Advances, and Practices for a Greener Future, looks at the application of a variety of technologies, both fundamental and advanced, that are being used for crop improvement, metabolic engineering, and the development of transgenic plants. The science of agriculture is among the oldest and most intensely studied by mankind. Human intervention has led to manipulation of plant gene structure for the use of plants for the production of bioenergy, food, textiles, among other industrial uses. A sound knowledge of enzymology as well as the various biosynthetic pathways is required to further utilize microbes as sources to provide the desired products for industrial utility. This volume provides an overview of all these aspects along with an updated review of the major plant biotechnology procedures and techniques, their impact on novel agricultural development, and crop plant improvement. Also discussed are the use of "white biotechnology" and "metabolic engineering" as prerequisites for a sustainable development. The importance of patenting of plant products, world food safety, and the role of several imminent organizations is also discussed. The volume provides an holistic view that makes it a valuable source of information for researchers of agriculture and biotechnology as well as agricultural engineers, environmental biologists, environmental engineers, and environmentalists. Short exercises at the end of the chapters help to make the book suitable for course work in agriculture biotechnology, genetics, biology, biotechnology, and plant science.

This two-volume textbook provides a comprehensive overview on the broad field of Animal Biotechnology with a special focus on livestock reproduction and breeding. The reader will be introduced to a variety of state-of-the-art technologies and emerging genetic tools and their applications in animal production. Also, ethics and legal aspects of animal biotechnology will be discussed and new trends and developments in the field will be critically assessed. The two-volume work is a must-have for graduate students, advanced undergraduates and researchers in the field of veterinary medicine, genetics and animal biotechnology. This first volume mainly focuses on artificial insemination, embryo transfer technologies in diverse animal species and cryopreservation of oocytes and embryos.

This book presents current research in the study of new technologies, developments and applications of microRNA and non-coding RNA. Topics include the role of microRNA and short interfering RNAs in plants; microRNAs, major affective disorders and suicidal behavior; microRNA in endoparasites; the functional roles of non-coding RNAs in glioma and their clinical implications; identifying miRNA function in innate immunity; and how multiple IsomiRs and diversity of miRNA sequences unveil evolutionary roles and functional relationships across animals.

Pluripotent cells of the early embryo originate all types of somatic cells and germ cells of adult organism. Pluripotent stems cell lines were derived from mammalian embryos and adult tissues using different techniques and from different sources. Despite different origin, all pluripotent stem cell lines demonstrate considerable similarity of the major biological properties. This book examines the fundamental mechanisms which regulate normal development of pluripotent cells into different lineages and are disrupted in cancer initiating cells. Analysis gene expression profiles, differentiation potentials and cell cycle of normal and mutant pluripotent stem cells provide new data to search molecular targets to eliminate malignant cells in tumours. In this book, the authors also aim to present a global picture of how extracellular signals, intracellular signal transduction pathways and transcriptional networks co-operate together to determine the cell fate of pluripotent stem cells. Practical, ethical and legal considerations that must be addressed before induced pluripotent stem (iPS) cells can realise their potential in the treatment of degenerative disease is discussed as well. Recent advancements in the cancer stem cell hypothesis are also summarised and the challenges associated with targeting resistant cancers in the context of stem cell microenvironments are presented.

* Six new chapters on vital topics of interest such as multilocus SNP genotyping (SNP chips), RNAi, ChIP-chip, and genomic tiling arrays* New edition responds to reviewers' and users' desire for greater coverage-now the most useful handbook on the market!* Practical, concise summary of everything about genomics and emerging technologies a busy physician or medical student should know* Covers concepts and techniques that are in use in medicine now, as well as those on the cutting-edge of science relevant to medicine, from bioinformatics to DNA diagnostics and proteomics*NEW: Includes chapter-end exercises, enhancing the utility of the new edition as a textbook*NEW: PowerPoint slides of images available at instructor website

Recent decades have seen tremendous changes in Latin America's agricultural sector, resulting from a broad program of liberalization instigated under pressure from the United States, the IMF, and the World Bank. Tariffs have been lifted, agricultural markets have been opened and privatized, land reform policies have been restricted or eliminated, and the perspective has shifted radically toward exportation rather than toward the goal of feeding local citizens. Examining the impact of these transformations, the contributors to Food for the Few: Neoliberal Globalism and Biotechnology in Latin America paint a somber portrait, describing local peasant farmers who have been made responsible for protecting impossibly vast areas of biodiversity, or are forced to specialize in one genetically modified crop, or who become low-wage workers within a capitalized farm complex. Using dozens of examples such as these, the deleterious consequences are surveyed from the perspectives of experts in diverse fields, including anthropology, economics, geography, political science, and sociology.

From Kathy McAfee's "Exporting Crop Biotechnology: The Myth of Molecular Miracles," to Liz Fitting's "Importing Corn, Exporting Labor: The Neoliberal Corn Regime, GMOs, and the Erosion of Mexican Biodiversity," Food for the Few balances disturbing findings with hopeful assessments of emerging grassroots alternatives. Surveying not only the Latin American conditions that led to bankruptcy for countless farmers but also the North's practices, such as the heavy subsidies implemented to protect North American farmers, these essays represent a comprehensive, keenly informed response to a pivotal global crisis.

This volume presents new research on messenger RNA (mRNA), the crucial mediating template between DNA and protein synthesis. In five chapters and several expert commentaries, international scientists examine major proteins involved in this transcription process, e.g., p38, a key proinflammatory-signaling molecule whose activity is being studied in order to develop inhibitors to treat rheumatoid arthritis and other chronic inflammatory diseases. Experimental methods and findings are presented relating to the role of mRNA in other clinical applications and to its basic role in gene expression. Illustrations include mRNA pathways for specific genes, mRNA encoding of proteins, and phylogenetic analysis diagrams. The editor's credentials are not given.

Potato is the most significant non-cereal crop. Much attention has been paid to this commercially important crop. The aim of this volume is to capture the recent advances made in improving potatoes using traditional breeding methods as well as genetic engineering technology. The book provides a critical appraisal of the state-of-the-art finding on this crop.

Embryonic stem cells have the ability to develop into virtually any cell in the body, and may have the potential to treat medical conditions such as diabetes and Parkinson's disease. In August 2001, President Bush announced that for the first time federal funds would be used to support research on human embryonic stem cells, but funding would be limited to 'existing stem cell lines'. The National Institutes of Health (NIH) has established the Human Embryonic Stem Cell Registry which lists stem cell lines that are eligible for use in federally funded research. Although 78 cell lines are listed, 21 embryonic stem cell lines are currently available. Scientists are concerned about the quality, longevity, and availability of the eligible stem cell lines. For a variety of reasons, many believe research advancement requires new embryonic stem cell lines, and for certain applications, stem cells derived from cloned embryos may offer the best hope for progress in understanding and treating disease. A significant cohort of pro-life advocates support stem cell research; those opposed are concerned that the isolation of stem cells requires the destruction of embryos. Letters from Congress, one signed by 206 Members of the House and a second signed by 58 Senators, have been sent urging President Bush to expand the current federal policy concerning embryonic stem cell research. Some have argued that stem cell research be limited to adult stem cells obtained from tissues such as bone marrow. They argue that adult stem cells should be pursued instead of embryonic stem cells because they believe the derivation of stem cells from either embryos or aborted foetuses is ethically unacceptable. Other scientists believe adult stem cells should not be the sole target of research because of important scientific and technical limitations. Groups make ethical distinctions in the debate on how to proceed with stem cell research based upon embryo protection, relief of suffering, viability, the purpose and timing of embryo creation and destruction, donor consent, scientific alternatives, federal funding, and cloning. Other countries are moving fast with active research programs. This book presents the current confused situation along with a selective bibliography.

Few scientific developments have given rise to as much controversy as biotechnology. Numerous groups are united in their opposition, expressing concern over environmental and health risks, impacts on rural livelihoods, the economic dominance of multinational companies and the ethical implications of crossing species boundaries. Among the supporters of the technology are those that believe in its potential to enhance food security, further economic development, increase productivity and reduce environmental pressures. As a result, countries - and sectors within countries - find themselves at odds with each other while potential opportunities for development offered by the use of biotechnology are seized or missed, and related risks go unmanaged. This book, a unique interdisciplinary collection of perspectives from the developing world, examines the ongoing debate. Writing for the International Centre for Trade and Sustainable Development, leading experts address issues such as diffusion of technology, intellectual property rights, the Cartagena Protocol, impacts of international trade, capacity building and biotechnology research and regulation. With the most recent and relevant examples from around the world, Trading in Genes offers the reader a single-volume overview of the connections between biotechnology, trade and sustainability that is both wide-ranging and thorough

The genetic engineering of food crops is an ecological hazard and health crisis that affects us all. Its consequences are global and potentially irrevocable. Yet the decision to use genetically modified organisms is currently being made for you by the government and major multinational corporations. To combat this practice, more than 600 scientists from 72 countries have called for a moratorium on the environmental release of GMOs. "GMO Free "is the most comprehensive resource available on the science behind this worldwide debate.

"

GMO Free "takes a good look at the evidence scientists have compiled, and makes a powerful case for a worldwide ban on GMO crops, to make way for a shift to sustainable agriculture and organic farming. It s time to take the future of your food supply and environment into your own informed hands. "GMO Free "will give you the information you need to do so. "

The book addresses some fundamental and profound questions such as: Are GM foods safe to eat? What do consumers think about GM foods and, alternatively, organic produce? What are the real risks of genetic pollution? And is it appropriate to delete a supposed gene for sadness? 'Recoding Nature' challenges the assumptions of those preparing the world for a 'recoded' DNA future. Recoding Nature is at the cutting edge of critical reflection about the 'biotechnology revolution', the redesign of nature through genetically modified plants, animals and even designer humans. The book addresses some fundamental and profound questions: Are GM foods safe to eat? What do consumers think about GM foods and, alternatively, organic produce? What are the real risks of genetic pollution? Is it appropriate to delete a supposed gene for sadness? Where did the idea of the DNA code come from, and how is it shaping thought for a genetics future? Why has commercial release of GM canola been approved when all canola-growing States have declared moratoriums? Does the biomedical approach really offer the way forward in health care? Are there genes for crime, or is this just an illusion? What about the prospects of corporate bioprospecting among Indigenous peoples? And why have large grass-roots movements in Asia surfaced to contest the notion that GM foods will feed the hungry? In fourteen essays by Australian and New Zealand writers critiquing the new biology, and with a stimulating foreword by Mae-Wan Ho - the UK scientist leading a global attack on genetic engineering as 'bad science' - Recoding Nature challenges the assumptions of those preparing the world for a 'recoded' DNA future.

This book is about an issue of our times which does not yet get the attention that it deserves - the growing dominance of huge transnational corporations over every aspect of our lives from executive super-pay to private sector pension funds. The authors of this book look at one particular kind of modern corporation - the hi-tech agro-chemical and genetic engineering companies that now dominate the food chain. In this richly detailed account, they show how a handful of companies have: - Accelerated the industrialization of agriculture and the integration of the global economy in order to gain an alarming control over the food chain. - Penetrated the previously independent world of scholarly research both in universities and the specialized international agricultural research centres in CGIAR. - Manipulated public opinion, including distorting our understanding of key environmental processes and issues. - Unduly influenced regulatory agencies and national governments. - Turned international bodies like the WTO, the World Bank, and the FAO into instruments devising rules and policies primarily of benefit to corporate growth and corporate profit. - And now are further expanding by bullying the governments and farmers of the developing countries to accept their technologies and products. Whether you are interested in the environment, democracy, or the development of countries in the South, the information and analysis contained in this book will prove both disturbing and empowering.

Scientists have developed a featherless chicken designed to make industrial chicken production more efficient, while specially trained Pacific bottlenose dolphins are being deployed in the Persian Gulf to disarm mines and protect our Navy. Everyone knows Darwin's theory of natural selection, but what about his idea of artificial selection--how humans, not nature, rework natural organisms to meet our needs? Industrializing Organisms brings us to the threshold of the new field of evolutionary history--from the mobilization of war horses in the 19th century to today's engineered plants and manipulated animals.

Eat Your Genes describes the genetic engineering techniques used in agriculture. It explores the food industry's commercial motivations, why certain crop modifications have predominated, and the importance of patenting to the genetic engineering enterprise. This book explains how crop segregation and labelling are central to the debate, and outlines the development of consumer resistance to the marketing of GM food in Europe. The potential health and ecological risks, the ethical issues, and the implications for both industrialized and developing countries are examined. The author argues that genetic engineering is still a long way from meeting its promises of feeding the world's hungry and contributing to a more eco-friendly agriculture. As the public debate over the desirability of GM food continues, this is the book to help you think through what is involved.

Providing the first account of the story behind genetically engineered plants, Paul F. Lurquin covers the controversial birth of the field, its sudden death, phoenixlike reemergence, and ultimate triumph as not only a legitimate field of science but a new tool of multinational corporate interests. In addition, Lurquin looks ahead to the potential impact this revolutionary technology will have on human welfare.

As Lurquin shows, it was the intense competition between international labs that resulted in the creation of the first transgenic plants. Two very different approaches to plant genetic engineering came to fruition at practically the same time, and Lurquin's account demonstrates how cross-fertilization between the two areas was critical to success. The scientists concerned were trying to tackle some very basic scientific problems and did not foresee the way that corporations would apply their methodology. With detailed accounts of the work of individual scientists and teams all over the world, Lurquin pieces together a remarkable account.

This title examines the impact of this potentially dangerous technology on food sources, animals, and our own bodies.

Cloning is one of the most hotly debated issues to have hit the world news in years. The first book of its kind. Flesh of My Flesh is a collection of articles by today's most-respected scientists, philosophers, bioethicists, theologians, and law professors about whether we should allow human cloning. The book includes historical pieces to provide background for the current debate. Religious, philosophical, and legal points of view are all represented. Flesh of My Flesh offers a fascinating and comprehensive look at this important and complex issue.

The ethics of animal genetic engineering, and controversies surrounding animal experimentation and welfare, are discussed in this book. Over 20 scientists, civil servants, biotechnology entrepreneurs, animal welfare campaigners and philosophers explore the various sides of the debate.